+86 137 2013 4139
+86 137 2013 4139
| CAS: | 2192215-81-7 | Cat No: | JKN00907 | Purity: | 98% |
Note: All products of the company are for scientific research only, and do not provide products and services for any individual
Product Description
| CAS | 2192215-81-7 | Cat No | JKN00907 | |
| Name | Ritlecitinib tosylate | |||
| Synonyms | Ritlecitinib tosylate | |||
| Smiles | C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3.CC1=CC=C(C=C1)S(=O)(=O)O | |||
| Chemical Name | 4-methylbenzenesulfonic acid;1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one | |||
| Formula | C22H27N5O4S | MWt | 457.5 | |
| Purity | 98% | Storage | Store at 4--8℃ | |
| Description | Ritlecitinib tosylate is an organosulfonate salt obtained by combining equimolar amounts of ritlecitinib and 4-toluenesulfonic acid. It is a kinase inhibitor, developed by Pfizer for the treatment of severe alopecia areata in adults and adolescents 12 years and older. It has a role as an anti-inflammatory drug, an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, an immunosuppressive agent, an antirheumatic drug and a dermatologic drug. It contains a ritlecitinib(1+). | |||
Product Documents
Menu
Contact Us
Tel: +86 137 2013 4139
E-mail: orders@jknbiochem.com
Add.:Room 2120, Office Building 2, No.1 Baisha Fifth Road, Hongshan District, Wuhan City, Hubei Province, China
Get In Touch
Get In Touch
